1. Inhibition of galectins in cancer: Biological challenges for their clinical application
    Diego José Laderach et al, 2023, Frontiers in Immunology CrossRef
  2. Galectin-9 is a target for the treatment of cancer: A patent review
    Cássia Ferreira Rodrigues et al, 2024, International Journal of Biological Macromolecules CrossRef
  3. An amperometric biosensor based on Cu2O@Au nanocomposites for the detection of galectin-1 via lactose–galectin interactions
    Feng Long et al, 2019, Nanotechnology CrossRef
  4. LGALS1 regulates cell adhesion to promote the progression of ovarian cancer
    Xuejian Li et al, 2023, Oncology Letters CrossRef
  5. New Treatment Strategy Targeting Galectin-1 against Thyroid Cancer
    Laetitia Gheysen et al, 2021, Cells CrossRef
  6. CCR5 is a prognostic biomarker and an immune regulator for triple negative breast cancer
    Xin Wang et al, 2021, Aging CrossRef
  7. Current and future markers for the diagnosis of thyroid cancer
    DESCAMPS Géraldine et al, 2019, Clinical Oncology and Research CrossRef
  8. Toward a new and noninvasive diagnostic method of papillary thyroid cancer by using peptide vectorized contrast agents targeted to galectin-1
    Deborah Fanfone et al, 2017, Medical Oncology CrossRef
  9. Histological Mapping and Subtype-Specific Functions of Galectins in Health and Disease
    Junko Nio-Kobayashi, 2018, Trends in Glycoscience and Glycotechnology CrossRef
  10. Galectins as pivotal components in oncogenesis and immune exclusion in human malignancies
    Nikiforos-Ioannis Kapetanakis et al, 2023, Frontiers in Immunology CrossRef
  11. Galectins and Carcinogenesis: Their Role in Head and Neck Carcinomas and Thyroid Carcinomas
    Nadège Kindt et al, 2017, International Journal of Molecular Sciences CrossRef
  12. Circulating galectin-1 delineates response to bevacizumab in melanoma patients and reprograms endothelial cell biology
    Nadia Bannoud et al, 2023, Proceedings of the National Academy of Sciences CrossRef
  13. Thyroid Nodules in Diagnostic Pathology: From Classic Concepts to Innovations
    Ilze Fridrihsone et al, 2018, Histopathology - An Update CrossRef
  14. Upregulation of LGALS1 is associated with oral cancer metastasis
    Ji-Min Li et al, 2018, Therapeutic Advances in Medical Oncology CrossRef
  15. Immunomodulation exerted by galectins: a land of opportunity in rare cancers
    Laura Díaz-Alvarez et al, 2023, Frontiers in Immunology CrossRef
  16. Molecular Imaging of Galectin-1 Expression as a Biomarker of Papillary Thyroid Cancer by Using Peptide-Functionalized Imaging Probes
    Deborah Fanfone et al, 2020, Biology CrossRef
  17. Altered profile of glycosylated proteins in serum samples obtained from patients with Hashimoto′s thyroiditis following depletion of highly abundant proteins
    Yaozheng Xu et al, 2023, Frontiers in Immunology CrossRef
  18. Association between high galectin expression and poor prognosis in hematologic cancers: a systematic review and meta-analysis
    Haotian Liu et al, 2023, Hematology CrossRef
  19. Comparative evaluation of BMI-1 proto-oncogene expression in normal tissue, adenoma and papillary carcinoma of human thyroid in pathology samples
    Mohadeseh Hajian et al, 2021, BMC Research Notes CrossRef
  20. The Extracellular Matrix-Derived Biomarkers for Diagnosis, Prognosis, and Personalized Therapy of Malignant Tumors
    Elena V. Petersen et al, 2020, Frontiers in Oncology CrossRef
  21. The Tumor Microenvironment and the Estrogen Loop in Thyroid Cancer
    Nerina Denaro et al, 2023, Cancers CrossRef
  22. Galectin-1 Restricts Vascular Smooth Muscle Cell Motility Via Modulating Adhesion Force and Focal Adhesion Dynamics
    Min-Shao Tsai et al, 2018, Scientific Reports CrossRef
  23. Circulating Immune Proteins: Improving the Diagnosis and Clinical Outcome in Advanced Non-Small Cell Lung Cancer
    Susana Torres-Martínez et al, 2023, International Journal of Molecular Sciences CrossRef

  24. The Blood Biomarkers of Thyroid Cancer


    Weiran Wang et al, 2020, Cancer Management and Research CrossRef
  25. The Role of Galectins in Cervical Cancer Biology and Progression
    Lufang Wang et al, 2018, BioMed Research International CrossRef
  26. Galectin-9 as a biomarker of disease severity
    Preeti Moar et al, 2021, Cellular Immunology CrossRef